Literature DB >> 7059323

Triglyceride and cholesterol metabolism in primary hypertriglyceridemia.

U Beil, S M Grundy, J R Crouse, L Zech.   

Abstract

To determine mechanisms of elevated plasma triglycerides (TG) in patients with primary hypertriglyceridemias, simultaneous studies were carried out on kinetics of very low density lipoprotein-triglycerides (VLDL-TG) and synthesis of cholesterol and bile acids. Sixteen hypertriglyceridemic patients with familial combined hyperlipidemia (FCHL) and 12 patients with poorly classified, primary hypertriglyceridemia were studied, and their results were compared to a series of normal and obese subjects previously studied in our laboratory. The mean value for transport (synthesis) of VLDL-TG in patients with FCHL was about twice normal. Although the upper normal synthesis rates overlapped with transport rates of some patients with FCHL, it appeared that the major cause of hypertriglyceridemia in FCHL was an elevated production of VLDL-TG. However, the height of the plasma TG in FCHL patients also was influenced by individual clearance capacities for VLDL-TG, and fractional clearance rates in several seemed particularly low. Synthesis rates for cholesterol and/or bile acids were high in several patients with FCHL, suggesting simultaneous overproduction of VLDL-TG and sterols; however, increased synthesis of both was not observed in all the patients. Most patients with poorly classified hypertriglyceridemia had over-production of VLDL-TG, but an apparent reduction in clearance was common. In these patients, increased synthesis of cholesterol and bile acids was infrequent. Our results indicate that abnormally high production of VLDL-TG seemed to be the major factor in causing primary hypertriglyceridemia, but that clearance capacity can play an important role in determining the the severity of the TG elevation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059323     DOI: 10.1161/01.atv.2.1.44

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  10 in total

1.  Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.

Authors:  D E Wilson; M Emi; P H Iverius; A Hata; L L Wu; E Hillas; R R Williams; J M Lalouel
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 2.  Chylomicronaemia--current diagnosis and future therapies.

Authors:  Amanda J Brahm; Robert A Hegele
Journal:  Nat Rev Endocrinol       Date:  2015-03-03       Impact factor: 43.330

3.  Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia.

Authors:  B Angelin; K S Hershon; J D Brunzell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.

Authors:  Y A Kesäniemi; W F Beltz; S M Grundy
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

5.  Studies of triacyglycerol structure of very low density lipoproteins of normolipemic subjects and patients with type III and type IV hyperlipoproteinemia.

Authors:  J J Myher; A Kuksis; W C Breckenridge; J A Little
Journal:  Lipids       Date:  1984-09       Impact factor: 1.880

Review 6.  Benefits of aerobic conditioning and diet for overweight adults.

Authors:  R D Hagan
Journal:  Sports Med       Date:  1988-03       Impact factor: 11.136

Review 7.  Molecular genetics of human lipoprotein lipase deficiency.

Authors:  M R Hayden; Y Ma
Journal:  Mol Cell Biochem       Date:  1992-08-18       Impact factor: 3.396

8.  Hypertriglyceridemia.

Authors:  Amanda Brahm; Robert A Hegele
Journal:  Nutrients       Date:  2013-03-22       Impact factor: 5.717

9.  Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application.

Authors:  Scott Q Siler
Journal:  Pharm Res       Date:  2022-05-24       Impact factor: 4.580

Review 10.  The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

Authors:  Robert A Hegele; Henry N Ginsberg; M John Chapman; Børge G Nordestgaard; Jan Albert Kuivenhoven; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Olivier S Descamps; G Kees Hovingh; Steve E Humphries; Petri T Kovanen; Luis Masana; Päivi Pajukanta; Klaus G Parhofer; Frederick J Raal; Kausik K Ray; Raul D Santos; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen; Gerald F Watts; Olov Wiklund
Journal:  Lancet Diabetes Endocrinol       Date:  2013-12-23       Impact factor: 32.069

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.